A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ursula A. Matulonis Suzanne E Dahlberg Christin Whalen Sara M Tolaney Eric Winer |
| Publication date | June 27, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |